As shown in Table 3, we found that BMI and DBP were positively associated with HMW APN in control subjects (R = .430, P = .011; R = .370, P = .031, respectively), similar to FPG (R = .350, P = .016) in NAFLD patients, while HMW APN was significantly and negatively correlated with ALT (R = −.321, P = .029) and AST (R = −0.295, P = .045) in NAFLD patients. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.